Lactation, Health, and Reproduction of Dairy Cows Receiving Daily Injectable or Sustained-Release Somatotropin

¹ Department of Animal and Poultry Science, University of Guelph, Guelph, ON, Canada N1G 2W1

Seventy-four Holstein cows (26 primiparous) were utilized to compare the efficacy and safety of sustained-release versus daily injectable formulations of recombinant bST. Twenty-four control cows were injected biweekly with oil microsphere; 25 cows were injected biweekly with 350 mg of bST microsphere; and 25 cows were injected daily with 10.3 mg of bST. Injections were initiated between wk 4 and 5 of lactation and continued for 280 d. Administration of bST caused a moderate increase in milk and FCM production and improved the efficiency of feed and energy conversions. Most health-related and reproduction-related variables did not differ among treatment groups. However, incidence of teat and udder disorders and feet and leg problems tended to be higher during the 40-wk injection period for the bST-treated cows than for the control cows. Incidence of GnRH therapy and number of days to first service were higher for daily bST-treated cows than for controls. No differences existed between sustained-release and daily bST-treated cows for any parameters monitored.

Key Words: somatotropin • milk production • health

Submitted on March 3, 1992
Accepted on July 20, 1992

This article has been cited by other articles:

				M. Carriquiry, W. J. Weber, and B. A. Crooker Administration of Bovine Somatotropin in Early Lactation: A Meta-Analysis of Production Responses by Multiparous Holstein Cows J Dairy Sci, July 1, 2008; 91(7): 2641 - 2652. [Abstract] [Full Text] [PDF]

				S. A. Balaguer, R. A. Pershing, C. Rodriguez-Sallaberry, W. W. Thatcher, and L. Badinga Effects of Bovine Somatotropin on Uterine Genes Related to the Prostaglandin Cascade in Lactating Dairy Cows J Dairy Sci, February 1, 2005; 88(2): 543 - 552. [Abstract] [Full Text] [PDF]